Sichuan Cancer Hospital and Institutechengdu, Sichuan, China
Disclosure information not submitted.
3035 - Sintilimab Combined with Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm, Multicenter, Phase 2 Trial
Tuesday, October 1, 202412:45 PM – 2:00 PM ET
